| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00029 | 1 |